HomenewsUncategorizedFTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics

FTC Moves to Block Amgen’s $27.8 Billion Deal for Horizon Therapeutics

  • May 16, 2023
  • Posted by: GMI-Co
  • Category: Uncategorized
No Comments

The FTC hasn’t often challenged mergers involving drugmakers, but under Chair Lina Khan it has taken a stricter stance on deals.



Leave a Reply